Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Diagnostics (Basel, Switzerland)|March 13, 2025
Bone-Specific Alkaline Phosphatase as a Complementary Diagnostic Marker for the Assessment of Children and Adolescents with Secondary OsteoporosisEunha Bae, Soo Yeun Sim, Su Jin Park, et al.
Experimental Eye Research|January 10, 2024
Sialylated IVIg promotes clinical improvements in a rabbit dry eye model by regulating inflammatory cytokinesHyeongjwa Choi, Ha-Eun Lee, Sung-Vin Lee, et al.
International Journal of Endocrinology|November 12, 2020
Association between Parent's Metabolic Syndrome and 12- to18-Year-Old Offspring's Overweight: Results from the Korea National Health and Nutrition Examination Survey (K-NHANES) 2009-2016Na Yeong Lee, Kyungdo Han, Yoonji Lee, et al.
Biomaterials|September 6, 2022
Novel antitumor therapeutic strategy using CD4<sup>+</sup> T cell-derived extracellular vesiclesSanghee Shin, Inseong Jung, Dokyung Jung, et al.
Journal of Extracellular Vesicles|November 30, 2022
Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA deliveryDokyung Jung, Sanghee Shin, Sung-Min Kang, et al.
Journal of Korean Medical Science|July 18, 2023
Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of AgeHye Jin Shi, Jinyoung Yang, Joong Sik Eom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract CancerYeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, et al.
Journal for Immunotherapy of Cancer|February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer typesJeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaChang Gon Kim, Min Hee Hong, Dahee Kim, et al.
Pageof 7